Irish Daily Mail

Now MS pills are used to ease agony of bowel disease

- BY CAMERON HENDERSON

ADRUG given to multiple sclerosis patients could be used to ease the pain of severe bowel disease. In a trial, patients with ulcerative colitis, which causes damage inside the gut, were given the pills and within a year a third were free from symptoms such as bloating, diarrhoea and pain.

Most had failed to respond to standard medication­s before being given the experiment­al treatment.

It is expected that health watchdog the National Institute for Health and Care Excellence (Nice) will approve the drug in the coming weeks.

Experts say the drug, called ozanimod, does not cause side effects, such as blood clots, seen with other colitis tablets. Sami Hoque, consultant gastroente­rologist and the trial’s chief investigat­or, said: ‘I have patients who have been on the tablets for three or four years and have practicall­y no symptoms.’

Ulcerative colitis affects about 10,000 in Ireland, along with Crohn’s, is one of two major types of inflammato­ry bowel disease.

In both conditions, the immune system goes into overdrive, attacking healthy tissue in the gut.

Inflammato­ry bowel disease can crop up at any age, although it usually develops in young adulthood.

Studies have shown that those of Ashkenazi Jewish heritage are more likely to suffer. While Crohn’s causes inflammati­on and ulcers throughout the digestive system, ulcerative colitis affects only the colon, or large bowel.

In the majority of cases, patients first visit their GP with bloating, diarrhoea, weight loss or blood in their stools.

If doctors suspect colitis, they take a stool sample to test for a protein called calprotect­in, which indicates inflammati­on in the gut.

Further internal scans are then performed to look for physical signs of damage.

Patients are given anti-inflammato­ry tablets or suppositor­ies called aminosalic­ylates, which help the tissue to repair itself, reducing pain and swelling. But these usually become less effective over time.

Other options include powerful steroids that lower inflammati­on by suppressin­g the immune system.

However, side effects include acne, mood swings and increased vulnerabil­ity to infections.

Patients have started to have access to drugs known as biologics, delivered via an intravenou­s drip in hospital.

These block fighter proteins called cytokines, which are sent out by the immune system and cause damage to the gut lining. But only a third of patients will respond to these, and, again, the medicine tends to lose effectiven­ess over time.

In the past year or so, Nice has approved another type of drug, called JAK inhibitors, for colitis. These pills, normally used to fight arthritis, change the way immune cells in the gut work, stopping them attacking healthy bowel tissue.

The compound vanishes from the system in 24 hours, meaning it does not suppress the immune system.

But the drugs are known to increase the risk of blood clots, meaning they are not used for those with high blood pressure and clotting disorders.

In clinical trials, ozanimod has proved just as effective as JAK inhibitors in patients who have not responded to previous treatments.

It works by binding to immune cells called lymphocyte­s, stopping them from going haywire and attacking the bowel.

In MS, lymphocyte­s attack the

Ozanimod does not cause side effects ‘It’s such a relief to find something that works’

brain and spinal cord – which ozanimod prevents.

‘Early trials have shown that about two-thirds of ulcerative colitis patients see a significan­t reduction in their symptoms with ozanimod, compared to around half on biologics,’ says Dr Hoque.

The treatment is not risk-free: there is a small chance it can slow the heart rate, so the drug is not recommende­d for patients with abnormal heart rhythms.

One patient to benefit from ozanimod is Albert Williamson-Taylor, a 63-year-old engineer. The father-of-four has suffered ulcerative colitis for 30 years, and all the treatments he tried had limited benefits.

In 2016, Albert was enrolled in a trial of ozanimod and he says: ‘Almost as soon as I started taking ozanimod, the stomach pain disappeare­d.

‘It’s such a relief to finally find something that works.’

 ?? ?? RELIEF: Albert Williamson-Taylor has had ulcerative colitis for 30 years
RELIEF: Albert Williamson-Taylor has had ulcerative colitis for 30 years

Newspapers in English

Newspapers from Ireland